Awaiting product image

High-Tech Patient Monitoring Systems Markets (Remote and Wireless Systems, Data Processing, EMR Data Transfer)

$3,500.00 – $7,000.00

SKU: KLI2155317 Category: Pages: 150

Description

New technologies are transforming patient monitoring and Kalorama Information has reported on these developments last year. This report, High-Tech Patient Monitoring market updates revenues and segment breakdowns to reflect changes in the market, particularly the remote monitoring and the enhanced role of applications to transfer patient data to EMR systems.

Advances in remote patient monitoring include new peripherals, real-time audio and video for “face-to-face” interaction between clinicians and patients, wireless communication, systems that “sort” the vast amount of data collected in order to put it into the context of a patient’s condition, portable and ambulatory monitors, web-based access to the patient record, systems that transfer data to an electronic medical record (EMR), and full-service outsourcing that includes a clinician to evaluate data and send a report to the attending physician.

Novel technologies in patient monitoring are emerging to meet the increasing demands of an aging population, decreasing healthcare resources, and an emphasis on reducing hospital days. Nearly all focus on some form of ambulatory monitoring using wired or wireless technologies.

This Kalorama Information report High-Tech Patient Monitoring Systems covers three product areas:

  • Wireless and Remote Patient Monitors,
  • Patient Data Processing Applications and Equipment,
  • EMR Data Transfer Equipment and Applications

Patient data processing applications and equipment use algorithms to evaluate monitoring measurements for a patient’s specific condition(s). Usually, these can be customized by the physician, with reports sent to the physician; these can be integrated parts of a PM system or add-ons. EMR data transfer equipment and applications for this report are either components of, or add-ons to, patient monitoring systems. This does not include EMR applications, simply the applications in this segment transfer data to third-party EMRs.
There are four primary markets for these new technologies, which are as follows:

  • Hospitals;
  • Home healthcare;
  • Nursing homes; and
  • Other, including first responders, institutional, physician offices, and military.

 

All market numbers in this report pertain to the U.S. market at the retail level. In most cases, retail level is the same as wholesale level because end users are purchasing directly from the vendor. The base year is 2008, with forecasts provided for each year through 2013.

The market was evaluated via a combination of disease prevalence trends, population trends, device innovations, federal and industry standards and regulations. As with all Kalorama Information reports, interviews were the key source of market information presented. Both primary and secondary sources were consulted in developing market estimates.

Table of Contents

TABLE OF CONTENTS

CHAPTER ONE: EXECUTIVE SUMMARY

  • Introduction
  • Scope and Methodology
  • Products
  • Issues and Trends
  • Size and Growth of the Market
  • Leading Competitors
  • Forecast

CHAPTER TWO: INTRODUCTION

  • Overview
  • Aging of the Population
  • New Technologies
    • Wireless Technologiies
    • Remote Monitoring
    • Telemedicine
    • Applications to Sort Data by Disease State
    • EMR (EHR) Data Transfer Applications and Equipment
  • Proven Cost Effectiveness
  • Barriers to Use of High-Tech Patient Monitoring Systems
  • Forecast

CHAPTER THREE: PRODUCTS

  • Overview
  • Offerings
    • Abbott
    • American Medical Development (AMD) Telemedicine Products
    • American TeleCare
    • Cardiocom
    • Carematix
    • Cybernet Medical Corporation
    • Drager Medical
    • GE Healthcare
    • Global Media
    • Honeywell HomMed
    • iMetrikus
    • InTouch Health
    • LifeWatch Technologies
    • MedApps
    • Medtronic
    • Philips Medical Systems
    • Roche
    • St. Jude Medical
    • Second Opinion Software
    • Viterion TeleHealthcare
    • Welch Allyn
    • WebVMC

CHAPTER FOUR: ISSUES AND TRENDS

  • Introduction
  • Issues and Trends Driving the Market
    • Aging of the Population
    • New Wireless Technologies
    • Decreasing Healthcare Resources
    • Emphasis on Reducing Hospital Days
    • Nursing Shortage
    • Cost Effectiveness
  • Issues and Trends in Patient Monitoring Technologies
    • Audio and Video
    • Algorithms to “Sort” Data or Trigger Alarms
    • Off-site Access to Data
    • Full-service Outsourcing
    • Data Management and the Electronic Medical Record
    • Turnkey Systems
    • Disease Management Kits
    • HIPAA
    • System Compatibility

CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

  • Overview
  • Disease States
  • Asthma
  • COPD
  • CHF
  • CHD
  • Diabetes
  • Total Market Size and Forecast
  • Technologies
    • Wireless and Remote Patient Monitors
    • Patient Data Processing Applications and Equipment
    • Equipment and Applications to Transfer Data to EMRs
  • End-User Markets
    • Hospitals
    • Home Healthcare
    • Nursing Homes
    • Other
  • Disease States
    • Asthma
    • COPD
    • CHF
    • CHD
    • Diabetes
    • Other

CHAPTER SIX: CORPORATE PROFILES

  • Introduction
  • Abbott Laboratories, Inc
  • GE Healthcare
  • Honeywell HomMed LLC
  • Medtronic, Inc.
  • Philips Medical Systems
  • Roche Diagnostics Corporation
  • Other Companies (Global Media Group LLC, iMetrikus, Inc, InTouch Health, LifeWatch Technologies, Inc., MedApps, Inc, St. Jude Medical, Inc., Viterion TeleHealthcare LLC, Welch Allyn Inc.)

APPENDIX A: REGULATORY AUTHORITIES AND ORGANIZATIONS

APPENDIX B: LIST OF COMPANIES

LIST OF EXHIBITS

CHAPTER ONE: EXECUTIVE SUMMARY

Table 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

Figure 1-1: The U.S. Market for High-Tech Patient Monitoring Systems 2007-2012

CHAPTER THREE PRODUCTS

Table 3-1: Select Patient Monitoring Systems

Table 3-1: Select Patient Monitoring Systems January 2008

CHAPTER FOUR: ISSUES AND TRENDS

  • Table 4-1: Projected Population of the United States, by Age: 2000 to 2050
  • Figure 4-1: Population Aged 65 and Over, and 85 and Over 2000 to 2050
  • Figure 4-2: Percent of Population Aged 65 and Over, and 85 and Over 2000 to 2050
  • Table 4-2: Resident Population Projections: 2007 to 2050,
  • Table 4-3: National Health Expenditure Amounts, by Type of Expenditure: Calendar Years 2001-2015 ($billions)
  • Figure 4-3 Per Capita Healthcare Expenditures, 2001-2015
  • Table 4-4: Per Capita Healthcare Expenditures, 2001-2015
  • Table 4-5: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006
  • Figure 4-4: Percent of Office-based Physicians Using EMRs, by Number of Physicians in Practice, 2006
  • Table 4-6: Percent of Office-based Physicians Using EMRs, 2001-2006
  • Figure 4-5: Percent of Office-based Physicians Using EMRs, 2001-2006
  • Table 4-7: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006
  • Figure 4-6: Percent of Medical Practices Using EMRs, by Selected Years: 2003-2006
  • Table 4-8: Percentage of Office-based Physicians Reporting Selected Features of Their System, According to Whether Medical Records Are Reported to Be Fully or Partially Electronic: United States, 2006
  • Table 4-9: Use of Electronic Medical Records by Location Characteristics of Office-based Physicians: United States, 2006
  • Figure 4-7: By Sector Contribution to the US GDP (2007)
  • Figure 4-8: The US Healthcare Spending (2005-2016)

CHAPTER FIVE: TOTAL MARKET SIZE AND FORECAST

  • Table 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012
  • Figure 5-1: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes 2007 and 2012
  • Table 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65 and Over 2007 and 2012
  • Figure 5-2: U.S. Prevalence of Asthma, COPD, CHF, CHD, and Diabetes Among Americans Aged 65 and Over 2007 and 2012
  • Table 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
  • Figure 5-3: U.S. Direct and Indirect Morbidity Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
  • Figure 5-4: Percent Distribution of U.S. Direct Costs of Asthma, COPD, CHF, CHD, and Diabetes 2007
  • Table 5-4: The U.S. Market for New Technologies in Patient Monitoring 2007-2013
  • Figure 5-5: The U.S. Market for New Technologies in Patient Monitoring 2007-2013
  • Table 5-5: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type (Wireless, Data Processing, EMR Data Transfer) 2007-2013
  • Figure 5-6: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2007-2013
  • Figure 5-7: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2007
  • Figure 5-8: The U.S. Market for New Technologies in Patient Monitoring, by Technology Type 2013
  • Table 5-6: The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2013
  • Figure 5-9: The U.S. Market for Wireless and Remote Patient Monitoring Technologies 2007-2013
  • Table 5-7: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2013
  • Figure 5-10: The U.S. Market for Patient Data Processing Applications and Equipment 2007-2013
  • Table 5-8: The U.S. Market for EMR Data Transfer Equipment and Applications 2007-2013
  • Figure 5-11: The U.S. Market for EMR Data Transfer Applications and Equipment 2007-2013
  • Table 5-9: The U.S. Market for New Technologies in Patient Monitoring, by End User (Hospitals, Home Healthcare, Nursing Homes, Other) 2007-2013
  • Figure 5-12: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals, Home Healthcare, Nursing Homes, Other) 2007-2013
  • Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals, Home Healthcare, Nursing Homes, Other) 2007
  • Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring, by End User Type (Hospitals, Home Healthcare, Nursing Homes, Other) 2013
  • Table 5-10: The U.S. Market for New Technologies in Patient Monitoring in Hospitals 2007-2013
  • Figure 5-13: The U.S. Market for New Technologies in Patient Monitoring in Hospitals 2007-2013
  • Table 5-11: The U.S. Market for New Technologies in Patient Monitoring in Home Healthcare 2007-2013
  • Figure 5-14: The U.S. Market for New Technologies in Patient Monitoring in Home Healthcare 2007-2013
  • Table 5-12: The U.S. Market for New Technologies in Patient Monitoring in Nursing Homes 2007-2013
  • Figure 5-15: The U.S. Market for New Technologies in Patient Monitoring in Nursing Homes 2007-2013
  • Table 5-13: The U.S. Market for New Technologies in Patient Monitoring in Other End Uses 2007-2013
  • Figure 5-16: The U.S. Market for New Technologies in Patient Monitoring in Other End Uses 2007-2013
  • Table 5-14: The U.S. Market for New Technologies in Patient Monitoring, by Disease State 2007-2013 (Asthma, COPD, CHF, CHD, Diabetes, Other)
  • Figure 5-17: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2007-2013
  • Figure 5-18: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2007
  • Figure 5-19: The U.S. Market for New Technologies in Patient Monitoring, by Disease State (Asthma, COPD, CHF, CHD, Diabetes, Other) 2013
  • Table 5-15: The U.S. Market for New Technologies in Patient Monitoring of Asthma 2007-2013 ($millions)
  • Figure 5-20: The U.S. Market for New Technologies in Patient Monitoring of Asthma 2007-2013 ($ millions)
  • Table 5-16: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2013
  • Figure 5-21: The U.S. Market for New Technologies in Patient Monitoring of COPD 2007-2013
  • Table 5-17: The U.S. Market for New Technologies in Patient Monitoring of CHF 2007-2013
  • Figure 5-22: The U.S. Market for New Technologies in Patient Monitoring of CHF 2007-2013
  • Table 5-18: The U.S. Market for New Technologies in Patient Monitoring of CHD 2007-2013
  • Figure 5-23: The U.S. Market for New Technologies in Patient Monitoring of CHD 2007-2013
  • Table 5-19: The U.S. Market for New Technologies in Patient Monitoring of Diabetes 2007-2013
  • Figure 5-24: The U.S. Market for New Technologies in Patient Monitoring of Diabetes 2007-2013
  • Table 5-20: The U.S. Market for New Technologies in Patient Monitoring of Other Conditions 2007-2013
  • Figure 5-25: The U.S. Market for New Technologies in Patient Monitoring of Other Conditions 2007-2013

CHAPTER SIX: CORPORATE PROFILES

  • Table 6-1: Other Companies and Products

 

Related products

H1N1 (Swine Influenza) Market Assessment (Latest Data, Company Profiles, Implications...Advances in Ophthalmology: Markets in the Treatment of Eye Disorders and Corrective...